Paulo J.C. Lin - Concepedia

Author

Paulo J.C. Lin

Also Known As

Lin, Paulo J C, Lin, Paulo J. C., Paulo J C Lin, Paulo J. C. Lin, Paulo J. Lin, Paulo J.C. Lin, Paulo J. C. Lin, Paulo JC Lin, Paulo Jc Lin, Paulo Lin

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Acuitas Therapeutics (Canada)University of Pennsylvania University of British Columbia BioNTech (Germany)Duke University

About

Paulo J.C. Lin is an author at Acuitas Therapeutics (Canada) specializing in medicine, nanomedicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	18	3.4K
2	Engineering	10	10	2K
3	Natural Sciences	3	3	155
4	Social Sciences	1	1	20
5	Biochemistry	1	1	20

Paulo J.C. Lin

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini, Immunity VaccinationNanomedicineCross-protectionMucosal VaccinationVaccine Development	2021	659
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA Nathan M. Belliveau, Jens Huft, Paulo J.C. Lin, Molecular Therapy — Nucleic Acids NanoparticlesNanotherapeuticsEngineeringLipid NanoparticlesGene Delivery	2012	646
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice Paul F. McKay, Kai Hu, Anna K. Blakney, Nature Communications	2020	460
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles Barbara L. Mui, Ying K. Tam, Muthusamy Jayaraman, Molecular Therapy — Nucleic Acids Cell-based Drug DeliveryNanomedicineEngineeringChain LengthMedicine	2013	459
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice Dorottya Laczkó, Michael J. Hogan, Sushila A. Toulmin, Immunity VaccinationHumoral Immune ResponsesVaccine DevelopmentVaccine TargetImmunology	2020	376
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels Tanja Rothgangl, Melissa K. Dennis, Paulo J.C. Lin, Nature Biotechnology	2021	352
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization Drew Weissman, Mohamad‐Gabriel Alameh, Thushan I. de Silva, Cell Host & Microbe Viral EvolutionViral PathogenesisImmunologyD614g Spike MutationVirology	2020	351
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA Sam Chen, Yuen Yi C. Tam, Paulo J.C. Lin, Journal of Controlled Release NanoparticlesNanomedicineEngineeringVivo PotencyLipid Nanoparticle Formulations	2016	334
The Cellular Mechanisms of Neuronal Swelling Underlying Cytotoxic Edema Ravi L. Rungta, Hyun B. Choi, John R. Tyson, Cell InflammationEpendymaAutophagyCell DeathBrain Injury	2015	251
Molecular fate-mapping of serum antibody responses to repeat immunization Ariën Schiepers, Marije F. L. van ’t Wout, Allison J. Greaney, Nature Autoimmune DiseaseMolecular Fate-mappingImmunologyAntibody ScreeningAutoimmunity	2023	163

Page 1